Windlas Biotech Limited (WINDLAS)의 가격은 얼마입니까?

Windlas Biotech Limited (WINDLAS)의 가격은 $12.15입니다.

Windlas Biotech Limited (WINDLAS)의 시가 총액은 무엇입니까?

Windlas Biotech Limited (WINDLAS)의 시가 총액은 $257.09M입니다.

Windlas Biotech Limited (WINDLAS) 가격 이력

Windlas Biotech Limited functions as a comprehensive contract development and manufacturing organization (CDMO). Its CDMO offerings span the full product lifecycle, encompassing initial discovery, subsequent development, licensing, and large-scale commercial production of various generic pharmaceutical and nutraceutical items. Through these services, it assists clients in bringing both established and innovative pharmaceutical and nutraceutical products to market, which are then sold under the clients' proprietary brand names. Beyond its CDMO segment, Windlas Biotech also develops and manufactures its own portfolio of domestic trade generics and over-the-counter (OTC) brands, catering to the nutritional, ayurvedic, wellness, and personal care sectors. These in-house products reach consumers via a dual distribution approach: traditional offline channels like distributors, stockists, retail pharmacies, and institutional tenders, alongside a robust online presence through various e-commerce platforms. The company's international reach extends through exports, primarily to markets such as Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. Established in 2001, Windlas Biotech is headquartered in Gurugram, India.

연도	성과
2026 (TTM)	8.60%
2025	-30.97%
2024	149.05%
2023	63.15%
2022	-15.79%
2021	0.00%

연도

성과

2026 (TTM)

8.60%

2025

-30.97%

2024

149.05%

2023

63.15%

2022

-15.79%

2021

0.00%

회사	주가	변동률 1년%	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$164.22	30.66%	DE
Takeda Pharmaceutical Company Limited 4502.T	$38.13	25.43%	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.28	19.62%	IN
Galderma Group AG GALD.SW	$214.53	25.84%	CH

회사

주가

변동률 1년%

국가